Vaccine News and Research

Latest Vaccine News and Research

New findings about naturally acquired immunity may help improve existing malaria vaccines

When you have become immune to malaria after having contracted the disease, it seems that the body uses a more efficient protection than if you have been vaccinated against the deadly disease.

12 Nov 2021

COVID-19 vaccination humoral immune response in individuals with diabetes

A new study investigated the humoral immune response and side effects related to COVID-19 vaccines in individuals with type 1 diabetes and type 2 diabetes.

12 Nov 2021

Potential remaining COVID-19 burden in European countries

The researchers suggest governments should implement public health policies and non-pharmaceutical efforts to encourage vaccine-induced immunity.

12 Nov 2021

SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses

Researchers from the US recently reported the preclinical development of a self-amplifying mRNA (SAM) vaccine that encodes a prefusion-stabilized SARS-CoV-2 spike glycoprotein.

12 Nov 2021

Immune responses with and without previous SARS-CoV-2 infection following single BNT162b2 vaccine dose

The Protective Immunity from T-cells to COVID-19 in Healthcare workers (PITCH) is a prospective, cohort, multi-center study enclosed within the SIREN study designed to assess the effectiveness of the BNT162b2 vaccine in healthcare workers.

12 Nov 2021

Research finds greater mortality risk among rural COVID patients in ICUs than urban counterparts

The earliest wave of COVID-19 spared much of rural America, striking people who live in urban areas with far more frequency. The latest surge was different, however. Nonmetropolitan COVID cases outpaced metropolitan ones. So did overall COVID mortality rates.

11 Nov 2021

Vaccinated patients hospitalized with COVID-19 in Norway spend fewer days in the hospital

A recent study looks at how mRNA vaccination affects hospitalization and ICU admission in COVID-19 breakthrough infections.

11 Nov 2021

Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds

A new study evaluates the safety, immunogenicity, and efficacy of the BNT162b2 in children who were 5 to 11 years of age.

11 Nov 2021

Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine

A group of scientists from Israel sought to evaluate the long-term effectiveness of the BioNTech/Pfizer mRNA BNT162b2 vaccine.

11 Nov 2021

Flu season emerging against the backdrop of COVID-19 pandemic

For the second straight year, flu season is emerging against the backdrop of the COVID-19 pandemic. While the number of flu cases was relatively low last year, experts at Johns Hopkins Medicine say that this year, it could be much higher.

11 Nov 2021

More than 11.4 million people in the UK receive COVID-19 booster jabs

The vital booster program has reached another milestone as more than 11.4 million people in the UK have now received their top-up jabs to maintain protection ahead of the winter months.

11 Nov 2021

KHN’s ‘What the Health?’: Why health care is so expensive, chapter $22K

Congress appears to be making progress on its huge social spending bill, but even if it passes the House as planned the week of Nov. 15, it's unlikely it can get through the Senate before the Thanksgiving deadline that Democrats set for themselves.

11 Nov 2021

University of Oxford begins Phase I trial to test Ebola vaccine

The University of Oxford have begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers - with the first vaccinations taking place today (Thursday, 11 November).

11 Nov 2021

New Delta sublineage shows no additional resistance to neutralization

Researchers are attempting to determine the ability of this new sublineage to avoid neutralization by antibodies elicited from vaccination.

11 Nov 2021

Immunity following COVID-19 vaccination and natural infection in India

The researchers evaluated immune response markers in a cross-section of people from the Indian state of West Bengal, including those vaccinated with either Covishield or Covaxin, the unvaccinated cohort, and the naturally infected.

11 Nov 2021

COVID-19 trends identified from multiple linked EHR

In this study, the sociodemographic factors, occurrence of health conditions, the effect of the first and second waves in England, and vaccination effects, were considered separately.

11 Nov 2021

Phage-like particle system provides a platform for quick and easy vaccine generation

In this study, researchers report on the development of a monovalent lambda PLP-based vaccine against SARS-CoV-2 or MERS-Cov through decoration with the spike RBD proteins from either virus.

11 Nov 2021

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19

In an attempt to study the safety and effectiveness of sotrovimab in more vulnerable patients suffering from mild to moderate symptoms of COVID-19, a multinational team of researchers conducted the COVID-19 Monoclonal antibody Efficacy Trial-Intent to Care Early (COMET-ICE) trial.

11 Nov 2021

New discovery could lead to the creation of a pan-coronaviruses vaccine

Next generation vaccines for Covid-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, concludes new research carried out by UCL scientists.

10 Nov 2021

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

A research group from the US (led by experts from Yale University School of Medicine) recently presented a case of an immunocompromised female patient with acquired deficiency of B lymphocytes who subsequently developed a protracted course of the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

10 Nov 2021